Testing effectiveness (Phase 2)UnknownNCT02638428
What this trial is testing
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Who this might be right for
Relapsed Pediatric Solid TumorRefractory Pediatric Solid TumorRelapsed Pediatric AML+1 more
Samsung Medical Center 90